|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0762 USD | -3.91% |
|
-3.91% | -47.81% |
| 05-05 | Shield Therapeutics plc, Q1 2026 Sales/ Trading Statement Call, May 05, 2026 | |
| 05-01 | EARNINGS AND TRADING: ProService Building Services lowers outlook | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SHIELD THERAPEUTICS PLC | Biopharmaceuticals | -3.91% | -3.91% | -47.81% | +97.92% | -86.87% | 87.67M |
-
|
-
|
-
|
- Stock Market
- Stocks
- STX Stock
- SHIE.F Stock
- Charts Shield Therapeutics plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
